Skip to main content
. 2016 Jun 26;32:105–115. doi: 10.1007/8904_2016_537

Table 2.

Process times of newborn screening

Countries DBS sampling NBS lab analysis Confirmation Treatment
Mean age (days) Age at start (days) Mean start (days) Mean end (days) Mean start (days)
Disorder: GA-I
Austria 2.3 3.8 11 14 14
Belgium (Flemish part) 2.2 4.2 10 12 14
Czech Republic 2.5 4.5 6 8 8
Denmark 2.5 4.5 5 12 na
Germany 2.2 3.2 11 16 14
Hungary 2.5 5.5 na na na
Netherlands 3.8 4.8 10 21 10
Portugal 2.2 4.2 8 na na
Spain 3.8 7.8 8 15 15
Iceland 3 6 9 23 23
Median 2.5 4.5 9 14.5 14
Disorder: IVA
Austria 2.3 3.8 11 14 14
Belgium (Flemish part) 2.2 4.2 10 12 14
Czech Republic 2.5 4.5 6 8 8
Germany 2.2 3.2 11 16 14
Hungary 2.5 5.5 na na na
Netherlands 3.8 4.8 10 21 10
Portugal 2.2 4.2 8 na na
Spain 3.8 7.8 8 15 15
Iceland 3 6 9 23 23
Median 2.5 4.5 9.5 15 14
Disorder: MMACBL
Austria 2.3 3.8 11 14 14
Belgium (Flemish part) 2.2 4.2 10 14 14
Denmark 2.5 4.5 5 15 15
Hungary 2.5 5.5 na na na
Portugal 2.2 4.2 8 na na
Spain 3.8 7.8 8 15 15
Iceland 3 6 9 23 23
Median 2.5 4.5 8.5 15 15
Disorder: PA
Austria 2.3 3.8 11 14 14
Belgium (Flemish part) 2.2 4.2 10 12 14
Denmark 2.5 4.5 5 15 15
Hungary 2.5 5.5 na na na
Portugal 2.2 4.2 8 na na
Spain 3.8 7.8 8 15 15
Iceland 3 6 9 23 23
Median 2.5 4.5 8.5 15 15

na data not available, DBS dried blood spot